Jay S. Stout - 23 Jul 2025 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Technology Officer
Signature: /s/ Tiago Girao, attorney-in-fact for Jay Stout
Issuer symbol: IMVT
Transactions as of: 23 Jul 2025
Net transactions value: -$50,911
Form type: 4
Filing time: 25 Jul 2025, 17:11:45 UTC
Previous filing: 11 Jul 2025
Next filing: 10 Oct 2025
SEC: View on sec.gov

Quoteable Key Fact

"Jay S. Stout filed Form 4 for Immunovant, Inc. (IMVT) on 25 Jul 2025."

Quick Takeaways

This page summarizes Jay S. Stout's Form 4 filing for Immunovant, Inc. (IMVT).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 25 Jul 2025, 17:11.

What Changed

Previous filing in this sequence was filed on 11 Jul 2025.
Current net transaction value: -$50,911.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stout Jay S	Chief Technology Officer	C/O IMMUNOVANT, INC., 320 W 37TH STREET, 6TH FLOOR, NEW YORK	/s/ Tiago Girao, attorney-in-fact for Jay Stout	25 Jul 2025	0001702969

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	$50,911	-2,805	-1.4%	$18.15	204,919	23 Jul 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Content

On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.